Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Hepatitis C

Free Subscription Articles published in Scand J Gastroenterol Retrieve available abstracts of 6 articles: HTML format

Single Articles

June 2021
1. WALDENSTROM J, Hellstrand K, Westin J, Nilsson S, et al
   Presence of interferon-lambda 4, male gender, absent/mild steatosis and low viral load augment antibody levels to hepatitis C virus.
   Scand J Gastroenterol. 2021 Jun 2:1-6. doi: 10.1080/00365521.2021.1922750.
   PubMed     Abstract available
   
   
   May 2021
2. WALDENSTROM J, Kaberg M, Alanko Blome M, Widell A, et al
   Absence of interferon-lambda 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection.
   Scand J Gastroenterol. 2021 May 25:1-7. doi: 10.1080/00365521.2021.1925956.
   PubMed     Abstract available
   
   
   
3. PIECHA F, Ganssler JM, Ozga AK, Wehmeyer MH, et al
   Evolution of liver stiffness and post-treatment surveillance by liver elastography for HCV patients in the DAA era.
   Scand J Gastroenterol. 2021 May 19:1-9. doi: 10.1080/00365521.2021.1915374.
   PubMed     Abstract available
   
   
   March 2021
4. STOY S, Terczynska-Dyla E, Veidal SS, Rigbolt K, et al
   Interferon lambda 4 genotype and pathway in alcoholic hepatitis.
   Scand J Gastroenterol. 2021;56:304-311.
   PubMed     Abstract available
   
   
   July 2020
5. ALDURAYWISH A, Ragheb M, Taher I, Louis N, et al
   Prevalence, risk factors and impact of occult HCV infection on liver morbidity among haemodialysis patients: hospital-based cross-sectional study.
   Scand J Gastroenterol. 2020 Jul 10:1-7. doi: 10.1080/00365521.2020.1790649.
   PubMed     Abstract available
   
   
   May 2020
6. KABERG M, Larsson SB, Jerkeman A, Nystedt A, et al
   High risk of non-alcoholic liver disease mortality in patients with chronic hepatitis C with illicit substance use disorder.
   Scand J Gastroenterol. 2020 May 1:1-7. doi: 10.1080/00365521.2020.1754456.
   PubMed     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: